A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy

NCT03400852 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

44

Enrollment

INDUSTRY

Sponsor class

Stopped Slow enrollment

Conditions

Muscular Dystrophy, Duchenne

Interventions

DRUG: MNK-1411
OTHER: Placebo

Sponsor

Mallinckrodt ARD LLC